Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 4,410,581 | 4,778,581 | +368,000 | 77,626 | 119,226 | 65.29% | +41,599 |
| CYTOKINETICS INC(CYTK) | 0 | 458,295 | +458,295 | 0 | 25,188 | 13.79% | +25,188 |
| Lyell Immunopharma, Inc.(LYEL) | 800,399 | 800,399 | 0 | 7,076 | 12,998 | 7.12% | +5,923 |
| Relay Therapeutics, Inc.(RLAY) | 1,000,000 | 1,000,000 | 0 | 3,460 | 5,220 | 2.86% | +1,760 |
| Xenon Pharmaceuticals Inc.(XENE) | 160,000 | 160,000 | 0 | 5,008 | 6,424 | 3.52% | +1,416 |
| Kura Oncology, Inc.(KURA) | 816,882 | 0 | -816,882 | 4,713 | 0 | — | -4,713 |
| Maze Therapeutics, Inc.(MAZE) | 2,111,919 | 522,657 | -1,589,262 | 25,913 | 13,552 | 7.42% | -12,361 |